Evidence map›Paper›PMID 32799873›Full record

ArticleMalaria journal2020

Combining next-generation indoor residual spraying and drug-based malaria control strategies: observational evidence of a combined effect in Mali.

Joseph Wagman, Idrissa Cissé, Diakalkia Kone, Seydou Fomba, Erin Eckert, Jules Mihigo, Elie Bankineza, Mamadou Bah, Diadier Diallo, Christelle Gogue and 6 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Observational
  7. Stratification and Adaptation of Malaria Control Interventions in Chad.Tropical medicine and infectious disease · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Joseph WagmanPATH, Washington, DC, USA. jwagman@path.org.ORCID http://orcid.org/0000-0002-5178-3098
Idrissa CisséProgramme National de Lutte contre le Paludisme, Bamako, Mali.
Diakalkia KoneProgramme National de Lutte contre le Paludisme, Bamako, Mali.
Seydou FombaProgramme National de Lutte contre le Paludisme, Bamako, Mali.
Erin EckertRTI International, Washington, DC, USA.
Jules MihigoPMI, USAID, Bamako, Mali.
Elie BankinezaAbt Associates, Bamako, Mali.
Mamadou BahAbt Associates, Bamako, Mali.
Diadier DialloMEASURE Evaluation, Bamako, Mali.
Christelle GoguePATH, Washington, DC, USA.
Kenzie TynuvPATH, Washington, DC, USA.
Andrew SaibuIVCC, Accra, Ghana.
Jason H RichardsonIVCC, Washington, DC, USA.
Christen FornadelIVCC, Washington, DC, USA.
Laurence SlutskerPATH, Seattle, WA, USA.
Molly RobertsonPATH, Washington, DC, USA.
Program for Appropriate Technology in Health · USCentre Pour le Développement des Vaccins-Mali · MLEcole Nationale d’Ingénieurs – Abderhamane Baba Touré · MLMali-Folkecenter · MLRTI International · US

Funding

Unitaid Market intervention to accelerate uptake of new vector control tools
6 · The paper itself

Abstract

backgroundSégou Region in central Mali is an area of high malaria burden with seasonal transmission. The region reports high access to and use of long-lasting insecticidal nets (LLINs), though the principal vector, Anopheles gambiae, is resistant to pyrethroids. From 2011 until 2016, several high-burden districts of Ségou also received indoor residual spraying (IRS), though in 2014 concerns about pyrethroid resistance prompted a shift in IRS products to a micro-encapsulated formulation of the organophosphate insecticide pirimiphos-methyl. Also in 2014, the region expanded a pilot programme to provide seasonal malaria chemoprevention (SMC) to children aged 3-59 months in two districts. The timing of these decisions presented an opportunity to estimate the impact of both interventions, deployed individually and in combination, using quality-assured passive surveillance data.

methodsA non-randomized, quasi-experimental time series approach was used to analyse monthly trends in malaria case incidence at the district level. Districts were stratified by intervention status: an SMC district, an IRS district, an IRS + SMC district, and control districts that received neither IRS nor SMC in 2014. The numbers of positive rapid diagnostic test (RDT +) results reported at community health facilities were aggregated and epidemiological curves showing the incidence of RDT-confirmed malaria cases per 10,000 person-months were plotted for the total all-ages and for the under 5 year old (u5) population. The cumulative incidence of RDT + malaria cases observed from September 2014 to February 2015 was calculated in each intervention district and compared to the cumulative incidence reported from the same period in the control districts.

resultsCumulative peak-transmission all-ages incidence was lower in each of the intervention districts compared to the control districts: 16% lower in the SMC district; 28% lower in the IRS district; and 39% lower in the IRS + SMC district. The same trends were observed in the u5 population: incidence was 15% lower with SMC, 48% lower with IRS, and 53% lower with IRS + SMC. The SMC-only intervention had a more moderate effect on incidence reduction initially, which increased over time. The IRS-only intervention had a rapid, comparatively large impact initially that waned over time. The impact of the combined interventions was both rapid and longer lasting.

conclusionEvaluating the impact of IRS with an organophosphate and SMC on reducing incidence rates of passive RDT-confirmed malaria cases in Ségou Region in 2014 suggests that combining the interventions had a greater effect than either intervention used individually in this high-burden region of central Mali with pyrethroid-resistant vectors and high rates of household access to LLINs.

Indexed as

AnophelesInsecticidesMosquito VectorsOrganothiophosphorus CompoundsAdolescentAdultAgedAged, 80 and overAnimalsAntimalarialsChildChild, PreschoolCommunicable Disease ControlHumansIncidenceInfantAntimalarialsInsecticidesOrganothiophosphorus CompoundsPesticide Residuespirimiphos methylCombined malaria control strategiesIndoor residual sprayingObservational analysisSeasonal malaria chemoprevention

Identifiers

PMID32799873
PMCPMC7429948
OpenAlexW3049261413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.